Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, presents a significant global health concern, especially in developing regions. Effective management of this infectious disease requires a comprehensive approach that encompasses timely diagnosis, appropriate treatment, and preventive measures.
Early diagnosis is crucial for effective enteric fever management. Blood culture remains the gold standard for diagnosis, although it's sensitivity can be limited. Rapid diagnostic tests, such as the Typhidot test, offer alternative methods for early detection, particularly in resource-limited settings.
Antimicrobial therapy is the mainstay of enteric fever treatment. However, the emergence of multi-drug resistant strains necessitates careful selection of antimicrobial agents. Current recommendations favor third-generation cephalosporins and fluoroquinolones. In severe cases, supportive care, including fluid and electrolyte management, is vital.
Prevention is integral to the comprehensive management of enteric fever. This includes vaccination, promoting hand hygiene, safe food handling practices, and access to clean water. The Ty21a and Vi polysaccharide vaccines have shown efficacy in reducing disease incidence.
Given the increasing incidence of drug-resistant enteric fever, antimicrobial stewardship is paramount. This involves judicious use of antimicrobials, regular susceptibility testing, and continuous surveillance of resistance patterns.
Effective management of enteric fever requires a multifaceted approach. Timely diagnosis, appropriate treatment, preventive measures, and antimicrobial stewardship are all vital components. Healthcare professionals play a key role in implementing these strategies, thereby reducing the morbidity and mortality associated with this infectious disease.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation